GPER and EGFR cross-talk highlight aldosterone- and MR antagonist-induced NO production in cultured endothelial cells
Renata Paredes, M. Verónica Donoso, Carlos F. Lagos, César Cárdenas, Claudio Acuña-Castillo, Daniel Valdes, Luis Constandil, Juan Pablo Huidobro-Toro · 2026
Read GPER and EGFR cross-talk highlight aldosterone- and MR antagonist-induced NO production in cultured endothelial cells by Renata Paredes, M. Verónica Donoso, Carlos F. Lagos, César Cárdenas, Claudio Acuña-Castillo, Daniel Valdes, Luis Constandil, Juan Pablo Huidobro-Toro (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13575614.txt.
Description
Renata Paredes and seven co-authors published a study in 2026 on how the hormone aldosterone opens blood vessels within minutes, and on the surprise side talents of the drugs that block it. Aldosterone's fast widening action does not fit its classic slow receptor pathway. The team suspected a different receptor, one also touched by estrogen signals and linked to a growth factor receptor.
In rat artery preparations and cultured vessel-lining cells, aldosterone triggered nitric oxide release and widening at tiny doses, with the two effects tracking closely. Three blocker drugs each stopped that response, as expected, but each also produced nitric oxide on its own. Computer docking supported direct fits into the alternative receptor. The blockers, it seems, are not mere blockers.
Catalog record
| CREATOR | Renata Paredes, M. Verónica Donoso, Carlos F. Lagos, César Cárdenas, Claudio Acuña-Castillo, Daniel Valdes, Luis Constandil, Juan Pablo Huidobro-Toro |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |